4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-111461
See remarks sold 15,000 shares at an average $48.45 ($726,730)
- See remarks acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B See remarks | 2024-10-01 | Option exercise 10b5-1 | +15,000 | $16.00 | $240,000 | 45,443 | D |
| Thunen Shelley B See remarks | 2024-10-01 | Sale 10b5-1 | −5,201 | $47.96 | $249,422 | 40,242 | D |
| Thunen Shelley B See remarks | 2024-10-01 | Sale 10b5-1 | −9,521 | $48.69 | $463,560 | 30,721 | D |
| Thunen Shelley B See remarks | 2024-10-01 | Sale 10b5-1 | −278 | $49.45 | $13,747 | 30,443 | D |
| Derivatives | |||||||
| Thunen Shelley B See remarks | 2024-10-01 | Option exercise · Stock option (right to buy) 10b5-1 | −15,000 | 83,367 | D | ||
| Open-market sales · 15,000 sh · avg $48.45 · $726,730 | |||||||
Loading xslF345X05/ownership.xml…